Nagano, Japan

Hitomi Matsuhashi

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Anaeropharma Science, Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hitomi Matsuhashi. Retrieved from https://idiyas.com/inventor/hitomi-matsuhashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Hitomi Matsuhashi in Gene Delivery Systems

Introduction: Hitomi Matsuhashi is a notable inventor based in Nagano, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of gene delivery systems. His work focuses on enhancing the efficiency of gene transport mechanisms, which is crucial for therapeutic applications.

Latest Patents: Matsuhashi holds a patent for a method of constructing a gene transport support. The patent outlines a method for efficiently creating a gene delivery carrier that exhibits favorable activity and expression efficiency of proteins expressed by introduced genes. This innovative approach involves using an anaerobic microorganism capable of thriving in tumor tissues, which can express proteins with antitumor activity or convert antitumor substance precursors into active forms.

Career Highlights: Matsuhashi is associated with Anaeropharma Science, Inc., where he continues to advance research in gene delivery technologies. His work is pivotal in developing pharmaceutical compositions that combine gene delivery carriers with therapeutic agents for solid tumors.

Collaborations: Matsuhashi collaborates with notable colleagues, including Yuko Shimatani and Yoshinori Hamaji, who contribute to the research and development efforts in his field.

Conclusion: Hitomi Matsuhashi's innovative work in gene delivery systems represents a significant advancement in biotechnology, with the potential to improve cancer therapies. His contributions are vital for the future of gene therapy and its applications in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…